Opioid prescription trends among American Head and Neck Society fellowship graduates

Abstract

AbstractBackgroundOpioids are commonly used to manage the pain of head and neck (HN) cancer patients.MethodsRetrospective cohort of graduates from American Head and Neck Society accredited fellowships from 1997 to 2018. The Center for Medicare and Medicaid Services Part D Provider Utilization and Payment database 2014–2019 was cross‐referenced with provider names to identify opioid prescription trends.ResultsFrom 2014 to 2019, there was no significant difference in the average number of opioid beneficiaries per provider (18.02 vs. 18.10, p = 0.586) or opioid claims per provider (28.06 vs. 26.73, p = 0.708). The average total opioid day supply per beneficiary declined from 11.09 to 7.05 days from 2014 to 2019 (p < 0.001). In 2019, providers in the Northeast had the lowest prescribed opioid day supply (3.67 days) compared to those from the South who had the highest (10.32 days).ConclusionsOpioid prescription length has significantly declined among HN surgeons, with variations across geographic regions.